drugset / Trial / NCT03760198

Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis

NCT03760198 ↗

Phase 3 Completed 220 enrolled Medy-Tox
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is intented to evaluate the efficacy and safety of MEDITOXIN compared to placebo in treatment of primary axillary hyperhidrosis.

Timeline

Start
2018-08-03
Primary completion
2019-07-03
Completion
2019-09-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Meditoxin Protein / enzyme biologic 50 iu Other